Remdesivir therapy for severe pediatric COVID-19 in Singapore: A single-center retrospective observational cohort study.
Valerie Xue Fen SeahRina Yue Ling OngKai Qian KamKoh Cheng ThoonNatalie Woon Hui TanJiahui LiKaren Donceras NaduaChia Yin ChongChee Fu YungPublished in: Health science reports (2023)
Our observational analysis was unable to detect any clear benefit of RDV in terms of reducing duration in HD/ICU. RDV was well-tolerated in children with severe COVID-19.